Abstract

Background25(OH) vitamin D levels may be low in patients with moderately or severely active inflammatory bowel diseases (IBD: Crohn’s disease and Idiopathic Ulcerative Colitis) but this is less clear in patients with mild or inactive IBD. Furthermore there is limited information of any family influence on 25(OH) vitamin D levels in IBD. As a possible risk factor we hypothesize that vitamin D levels may also be low in families of IBD patients.ObjectivesTo evaluate 25[OH] vitamin D levels in patients with IBD in remission or with mild activity. A second objective is to evaluate whether there are relationships within IBD family units of 25[OH] vitamin D and what are the influences associated with these levels.MethodsParticipants underwent medical history, physical examination and a 114 item diet questionnaire. Serum 25[OH] vitamin D was measured, using a radioimmunoassay kit, (replete ≥ 75, insufficient 50–74, deficient < 25–50, or severely deficient < 25 nmol/L). Associations between 25[OH] vitamin D and twenty variables were evaluated using univariate regression. Multivariable analysis was also applied and intrafamilial dynamics were assessed.Results55 patients and 48 controls with their respective families participated (N206). 25[OH] vitamin D levels between patients and controls were similar (71.2 ± 32.8 vs. 68.3 ±26.2 nmol/L). Vitamin D supplements significantly increased intake but correlation with serum 25[OH] vitamin D was significant only during non sunny months among patients. Within family units, patients’ families had mean replete levels (82.3 ± 34.2 nmol/L) and a modest correlation emerged during sunny months between patients and family (r2 =0.209 p = 0.032). These relationships were less robust and non significant in controls and their families.ConclusionsIn patients with mild or inactive IBD 25[OH] vitamin D levels are less than ideal but are similar to controls. Taken together collectively, the results of this study suggest that patient family dynamics may be different in IBD units from that in control family units. However contrary to the hypothesis, intra familial vitamin D dynamics do not pose additional risks for development of IBD.

Highlights

  • The discovery of immunoregulatory and antineoplastic functions of vitamin D was followed by research to evaluate its possible pathogenic and therapeutic roles in multiple diseases [1,2,3]

  • The results of this study suggest that patient family dynamics may be different in inflammatory bowel diseases (IBD) units from that in control family units

  • Seasonal effects and the intake of vitamin D supplements appeared to be more evident in the IBD family unit largely driven by patients reactions

Read more

Summary

Introduction

The discovery of immunoregulatory and antineoplastic functions of vitamin D was followed by research to evaluate its possible pathogenic and therapeutic roles in multiple diseases [1,2,3]. Sunshine and UVB are hypothesized to have beneficial effects [2]. Both diseases have been associated with lower serum 25[OH] vitamin D levels [16,17] but the association is stronger with CD [2,18,19,20,21,22,23]. Evaluation of 25[OH] vitamin D levels in patients with moderate or severe IBD have shown low levels [16,17] but mild or inactive IBD has been studied less frequently

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call